Latest Total Nutraceutical (ERGO) Headlines
GROH(R) Beauty Line Wins Two Readers' Choice Awards
Marketwire - Thu Feb 13, 2:15PM CST
Entia Biosciences, Inc. (OTCQB: ERGO) and its wholly owned subsidiary Total Nutraceutical Solutions (TNS) has been notified that its GROH(R) Ergo Boost All-natural Hair and scalp conditioning treatment has received Readers' Choice awards in both the women's and men's hair care product categories from Beauty Launchpad magazine. The GROH Ergo Boost(R) product line, which addresses hair growth and scalp health with a revolutionary blend of Vitamin D infused argan oil and the powerful natural antioxidant L-Ergothioneine, has been selected best new "Women's Thinning Regimen" and "Men's Thinning Treatment" for 2013.
GROH(R) Reaches Important Milestone With Strategic Partner Mario Tricoci Salon Group
Marketwire - Thu Jan 23, 9:00AM CST
Entia Biosciences, Inc. (OTCQB: ERGO) and its wholly owned subsidiary Total Nutraceutical Solutions (TNS) today announced that the Mario Tricoci Group of salons and day spas, a leading member of the Elizabeth Arden Red Door salon and spa network, will officially launch the entire GROH(R) Ergo Boost product and professional services line on February 1st, 2014. This important milestone and strategic partnership follows an eight month evaluation of the GROH(R) PRO hair and scalp treatment, a deep conditioning back-bar therapy, currently being performed to more than 400 guests per week at Tricoci's seventeen locations. The launch of the full GROH(R) line is further validation of the market interest in the GROH(R) brand and Entia's commercialization strategy for its biotechnology and patent portfolio.
PubNub and Ford AppLink Showcase the Power of the "Internet of Things" with Real-Time Vehicle Dispatch App
PR Newswire - Tue Jan 07, 7:30PM CST
CES - PubNub, the only global Real-Time Network, today announced it is showcasing its winning makeathon integration with the Ford AppLink platform at Ford's booth at CES (North Hall #2222). PubNub was selected as a winner of the VentureBeat and Ford Motor Co. Makeathon for building a real-time dispatch app on PubNub and Ford AppLink. The app provides real-time location tracking and notification via mobile phone to a car's dashboard, bringing Internet of Things communication and technology to cars.
Expanded GROH(R) Line of Natural Beauty Products to Be Launched at Intercoiffure America/Canada
Marketwire - Thu Oct 17, 2:42PM CDT
Total Nutraceutical Solutions, the wholly-owned consumer products subsidiary of Entia Biosciences (OTCQB: ERGO), today announced that it will be launching its GROH Ergo Boost(R) line of all natural Professional Service and Consumer beauty products for the salon industry at the Fall Atelier Intercoiffure America/Canada on October 20th and 21st. Sponsored by L'Oreal's Professional Products division, the Fall Atelier event will be held at the elegant Waldorf Astoria Hotel in New York and is expected to be one of the largest gatherings of salon owners and stylists in North America.
Entia Biosciences' ErgoD2(TM) Could Effectively Treat Parkinson's Disease
ACCESSWIRE - Thu Sep 12, 10:56AM CDT
Entia Biosciences Inc. (OTC Markets: ERGO), a biotechnology company focused on the clinical effects of oxidative stress and free radical reactions in food sciences, has developed a unique compound that combines the power of vitamin D2 with that of ergothioneine. The combination could provide a clinically meaningful response in Parkinson's Disease and a number of other conditions, potentially making the nutritional supplement developer a very lucrative investment.
Entia Biosciences Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
ACCESSWIRE - Tue Sep 03, 1:35PM CDT
SHERWOOD, OR, September 3, 2013 - (ACCESSWIRE) - Entia Biosciences (OTCQB: ERGO), today announced it will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 8-10, 2013, at the Millennium Broadway Hotel in New York City.
Entia Biosciences: Unlocking the Full Potential of Ergothioneine
ACCESSWIRE - Thu Aug 29, 9:30AM CDT
Ergothioneine is a naturally occurring amino acid with antioxidant properties. It is commonly found in liver, kidney, black beans, kidney beans and oat bran, as well as bolete and oyster mushrooms. In the late-1920's, human blood testing conducted by researchers (Salt, 1939) showed "normal" ergothioneine levels that were nearly double more recent 2010 results found in a study conducted by Pennsylvania State University (Weigand-Heller, 2012).
Entia Biosciences (ERGO) Cornering the Market on Ergothioneine
ACCESSWIRE - Wed Aug 28, 12:02PM CDT
Ergothioneine is a naturally occurring amino acid with antioxidant properties. It is commonly found in liver, kidney, black beans, kidney beans and oat bran, as well as bolete and oyster mushrooms. In the late-1920's, human blood testing conducted by researchers (Salt, 1939) showed "normal" ergothioneine levels that were nearly double more recent 2010 results found in a study conducted by Pennsylvania State University (Weigand-Heller, 2012).
Entia Biosciences Completes Parkinson's Disease Study
ACCESSWIRE - Mon Aug 26, 10:50AM CDT
SHERWOOD, OR, August 26, 2013 -(ACCESSWIRE)- Entia Biosciences (OTCQB: ERGO), a food science biotechnology company and emerging leader in the field of Nutrigenomics, has completed a Parkinson's disease study in the Neurochemistry Laboratory of Dr. Jack Rogers at Massachusetts General Hospital, Charlestown, MA. The results from the study have been submitted to a peer-reviewed medical journal and the paper is entitled: "Improved Grip Strength and Alpha-Synuclein Levels in a Parkinson's disease Mouse Model Using the Novel Antioxidant Medical Food ErgoD2."
Entia Files PCT Patent on Athletic Performance
ACCESSWIRE - Wed Jul 03, 9:05AM CDT
Sherwood, OR, July 3, 2013 - (eTeligis via Accesswire) - Entia Biosciences (OTCQB: ERGO), a food science biotechnology company and emerging leader in the field of Nutrigenomics, announced today that it has filed a PCT patent covering the use of Ergothioneine (Ergo) and/or Vitamin D2 (Ergocalciferol) to physiologically support and improve athletic performance (strength, endurance, balance, and conditioning), prevent and repair injuries, improve muscular dysfunction in diseases (Parkinson's disease, multiple sclerosis), and maintain normal muscle cellular health by increasing the oxygen carrying capacity of blood. This invention also relates to the use of these powerful antioxidants in pharmaceutical, nutraceutical, functional ingredients, and medical food compositions to increase blood iron levels, percentage iron saturation, and production of important bioactive molecules, including but not limited to glutathione, alpha synuclein, and IL6. Extraction of Ergo and Vitamin D2 from whole food sou
Entia's Organic Vitamin D Enrichment Process Receives US Patent
ACCESSWIRE - Mon Jun 17, 2:33PM CDT
Penn State Research Foundation Expands Company's Exclusive License
Entia hires director of marketing for medical foods and consumer products
PR Newswire - Wed May 15, 1:08PM CDT
Entia Biosciences, Inc. (OTCQB: ERGO) announced today it has hired Sabrina Jetton to spearhead the Company's product innovation, communications, and branding initiatives as Director of Marketing. Since joining the team in April, Jetton has been leading the preparations for the upcoming launch of the expanded GROH® hair care and beauty line, which will be introduced May 19-20 during the Spring Symposium of Intercoiffure in Hollywood, Florida.
Entia Receives Notices of Allowance for its Ergothioneine and Genetic Transporter Patents from the United States, Canada, and Israel
PR Newswire - Tue Apr 02, 11:10AM CDT
Entia Biosciences (OTCQB: ERGO), a food science biotechnology company and emerging leader in the field of Nutrigenomics, has now received three Patent Notices of Allowance covering the use of Ergothioneine and its genetic transporter in the treatment of a wide variety of diseases, including those affecting the immune and central nervous systems. Notices from the United States Patent and Trademark Office and the Israel Patent Office were received in March and from the Canadian Intellectual Property Office in December.
Entia Biosciences Receives Expanded USDA Organic Certification
PR Newswire - Thu Feb 28, 9:00AM CST
Entia Biosciences, Inc. (OTCQB: ERGO) (ENTIA) announced today that its USDA organic certification for manufacturing and handling has been expanded to include the extraction and processing of two new mushroom-based ingredients developed by Entia and its academic research partners. Ergo Essence(TM) and Chitin-Glucan Complex(TM) are functional ingredients extracted from the whole food that contain naturally high concentrations of L-Ergothioneine (Ergo), Ergocalciferol (vitamin D2), and other important nutrients that Entia research has shown play an important role in cell health and rejuvenation. Entia expects to begin incorporating these new "100% USDA Organic" ingredients into its expanded GROH® hair care and cosmetics line which will be introduced to the beauty industry later this year.
Entia Receives Canadian Patent Notice of Allowance for Use of Ergothioneine and its Genetic Transporter
PR Newswire - Mon Dec 17, 9:00AM CST
Entia Biosciences (OTCBB: ERGO), a food science biotechnology company and emerging leader in the fields of Nutrigenomics and Targeted Nutrition, has received a Patent Notice of Allowance from the Canadian Intellectual Property Office covering the use of Ergothioneine and its genetic transporter (SLC22A4) in the treatment of a wide variety of diseases, including those affecting the immune and central nervous systems. Ergothioneine is a powerful amino acid and master antioxidant that is acquired exclusively from the diet and carried by this unique and specific transporter to cells throughout the body that are fighting damage and death from oxidative stress and toxic free radical reactions. Research conducted by Entia since 2011 has confirmed significant transporter activity in diabetes, arthritis, and several other serious non-communicable chronic conditions, suggesting an important physiologic role for Ergothioneine in diseases affecting millions of people world-wide.
GROH(R) Beauty Line Wins Two Readers' Choice Awards
Marketwire - Thu Feb 13, 2:15PM CST
Entia Biosciences, Inc. (OTCQB: ERGO) and its wholly owned subsidiary Total Nutraceutical Solutions (TNS) has been notified that its GROH(R) Ergo Boost All-natural Hair and scalp conditioning treatment has received Readers' Choice awards in both the women's and men's hair care product categories from Beauty Launchpad magazine. The GROH Ergo Boost(R) product line, which addresses hair growth and scalp health with a revolutionary blend of Vitamin D infused argan oil and the powerful natural antioxidant L-Ergothioneine, has been selected best new "Women's Thinning Regimen" and "Men's Thinning Treatment" for 2013.
GROH(R) Reaches Important Milestone With Strategic Partner Mario Tricoci Salon Group
Marketwire - Thu Jan 23, 9:00AM CST
Entia Biosciences, Inc. (OTCQB: ERGO) and its wholly owned subsidiary Total Nutraceutical Solutions (TNS) today announced that the Mario Tricoci Group of salons and day spas, a leading member of the Elizabeth Arden Red Door salon and spa network, will officially launch the entire GROH(R) Ergo Boost product and professional services line on February 1st, 2014. This important milestone and strategic partnership follows an eight month evaluation of the GROH(R) PRO hair and scalp treatment, a deep conditioning back-bar therapy, currently being performed to more than 400 guests per week at Tricoci's seventeen locations. The launch of the full GROH(R) line is further validation of the market interest in the GROH(R) brand and Entia's commercialization strategy for its biotechnology and patent portfolio.
PubNub and Ford AppLink Showcase the Power of the "Internet of Things" with Real-Time Vehicle Dispatch App
PR Newswire - Tue Jan 07, 7:30PM CST
CES - PubNub, the only global Real-Time Network, today announced it is showcasing its winning makeathon integration with the Ford AppLink platform at Ford's booth at CES (North Hall #2222). PubNub was selected as a winner of the VentureBeat and Ford Motor Co. Makeathon for building a real-time dispatch app on PubNub and Ford AppLink. The app provides real-time location tracking and notification via mobile phone to a car's dashboard, bringing Internet of Things communication and technology to cars.
Expanded GROH(R) Line of Natural Beauty Products to Be Launched at Intercoiffure America/Canada
Marketwire - Thu Oct 17, 2:42PM CDT
Total Nutraceutical Solutions, the wholly-owned consumer products subsidiary of Entia Biosciences (OTCQB: ERGO), today announced that it will be launching its GROH Ergo Boost(R) line of all natural Professional Service and Consumer beauty products for the salon industry at the Fall Atelier Intercoiffure America/Canada on October 20th and 21st. Sponsored by L'Oreal's Professional Products division, the Fall Atelier event will be held at the elegant Waldorf Astoria Hotel in New York and is expected to be one of the largest gatherings of salon owners and stylists in North America.
Entia Biosciences' ErgoD2(TM) Could Effectively Treat Parkinson's Disease
ACCESSWIRE - Thu Sep 12, 10:56AM CDT
Entia Biosciences Inc. (OTC Markets: ERGO), a biotechnology company focused on the clinical effects of oxidative stress and free radical reactions in food sciences, has developed a unique compound that combines the power of vitamin D2 with that of ergothioneine. The combination could provide a clinically meaningful response in Parkinson's Disease and a number of other conditions, potentially making the nutritional supplement developer a very lucrative investment.
Entia Biosciences Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
ACCESSWIRE - Tue Sep 03, 1:35PM CDT
SHERWOOD, OR, September 3, 2013 - (ACCESSWIRE) - Entia Biosciences (OTCQB: ERGO), today announced it will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 8-10, 2013, at the Millennium Broadway Hotel in New York City.
Entia Biosciences: Unlocking the Full Potential of Ergothioneine
ACCESSWIRE - Thu Aug 29, 9:30AM CDT
Ergothioneine is a naturally occurring amino acid with antioxidant properties. It is commonly found in liver, kidney, black beans, kidney beans and oat bran, as well as bolete and oyster mushrooms. In the late-1920's, human blood testing conducted by researchers (Salt, 1939) showed "normal" ergothioneine levels that were nearly double more recent 2010 results found in a study conducted by Pennsylvania State University (Weigand-Heller, 2012).
Entia Biosciences (ERGO) Cornering the Market on Ergothioneine
ACCESSWIRE - Wed Aug 28, 12:02PM CDT
Ergothioneine is a naturally occurring amino acid with antioxidant properties. It is commonly found in liver, kidney, black beans, kidney beans and oat bran, as well as bolete and oyster mushrooms. In the late-1920's, human blood testing conducted by researchers (Salt, 1939) showed "normal" ergothioneine levels that were nearly double more recent 2010 results found in a study conducted by Pennsylvania State University (Weigand-Heller, 2012).
Entia Biosciences Completes Parkinson's Disease Study
ACCESSWIRE - Mon Aug 26, 10:50AM CDT
SHERWOOD, OR, August 26, 2013 -(ACCESSWIRE)- Entia Biosciences (OTCQB: ERGO), a food science biotechnology company and emerging leader in the field of Nutrigenomics, has completed a Parkinson's disease study in the Neurochemistry Laboratory of Dr. Jack Rogers at Massachusetts General Hospital, Charlestown, MA. The results from the study have been submitted to a peer-reviewed medical journal and the paper is entitled: "Improved Grip Strength and Alpha-Synuclein Levels in a Parkinson's disease Mouse Model Using the Novel Antioxidant Medical Food ErgoD2."
Entia Files PCT Patent on Athletic Performance
ACCESSWIRE - Wed Jul 03, 9:05AM CDT
Sherwood, OR, July 3, 2013 - (eTeligis via Accesswire) - Entia Biosciences (OTCQB: ERGO), a food science biotechnology company and emerging leader in the field of Nutrigenomics, announced today that it has filed a PCT patent covering the use of Ergothioneine (Ergo) and/or Vitamin D2 (Ergocalciferol) to physiologically support and improve athletic performance (strength, endurance, balance, and conditioning), prevent and repair injuries, improve muscular dysfunction in diseases (Parkinson's disease, multiple sclerosis), and maintain normal muscle cellular health by increasing the oxygen carrying capacity of blood. This invention also relates to the use of these powerful antioxidants in pharmaceutical, nutraceutical, functional ingredients, and medical food compositions to increase blood iron levels, percentage iron saturation, and production of important bioactive molecules, including but not limited to glutathione, alpha synuclein, and IL6. Extraction of Ergo and Vitamin D2 from whole food sou
Entia's Organic Vitamin D Enrichment Process Receives US Patent
ACCESSWIRE - Mon Jun 17, 2:33PM CDT
Penn State Research Foundation Expands Company's Exclusive License
Entia hires director of marketing for medical foods and consumer products
PR Newswire - Wed May 15, 1:08PM CDT
Entia Biosciences, Inc. (OTCQB: ERGO) announced today it has hired Sabrina Jetton to spearhead the Company's product innovation, communications, and branding initiatives as Director of Marketing. Since joining the team in April, Jetton has been leading the preparations for the upcoming launch of the expanded GROH® hair care and beauty line, which will be introduced May 19-20 during the Spring Symposium of Intercoiffure in Hollywood, Florida.
Entia Receives Notices of Allowance for its Ergothioneine and Genetic Transporter Patents from the United States, Canada, and Israel
PR Newswire - Tue Apr 02, 11:10AM CDT
Entia Biosciences (OTCQB: ERGO), a food science biotechnology company and emerging leader in the field of Nutrigenomics, has now received three Patent Notices of Allowance covering the use of Ergothioneine and its genetic transporter in the treatment of a wide variety of diseases, including those affecting the immune and central nervous systems. Notices from the United States Patent and Trademark Office and the Israel Patent Office were received in March and from the Canadian Intellectual Property Office in December.
Entia Biosciences Receives Expanded USDA Organic Certification
PR Newswire - Thu Feb 28, 9:00AM CST
Entia Biosciences, Inc. (OTCQB: ERGO) (ENTIA) announced today that its USDA organic certification for manufacturing and handling has been expanded to include the extraction and processing of two new mushroom-based ingredients developed by Entia and its academic research partners. Ergo Essence(TM) and Chitin-Glucan Complex(TM) are functional ingredients extracted from the whole food that contain naturally high concentrations of L-Ergothioneine (Ergo), Ergocalciferol (vitamin D2), and other important nutrients that Entia research has shown play an important role in cell health and rejuvenation. Entia expects to begin incorporating these new "100% USDA Organic" ingredients into its expanded GROH® hair care and cosmetics line which will be introduced to the beauty industry later this year.
Entia Receives Canadian Patent Notice of Allowance for Use of Ergothioneine and its Genetic Transporter
PR Newswire - Mon Dec 17, 9:00AM CST
Entia Biosciences (OTCBB: ERGO), a food science biotechnology company and emerging leader in the fields of Nutrigenomics and Targeted Nutrition, has received a Patent Notice of Allowance from the Canadian Intellectual Property Office covering the use of Ergothioneine and its genetic transporter (SLC22A4) in the treatment of a wide variety of diseases, including those affecting the immune and central nervous systems. Ergothioneine is a powerful amino acid and master antioxidant that is acquired exclusively from the diet and carried by this unique and specific transporter to cells throughout the body that are fighting damage and death from oxidative stress and toxic free radical reactions. Research conducted by Entia since 2011 has confirmed significant transporter activity in diabetes, arthritis, and several other serious non-communicable chronic conditions, suggesting an important physiologic role for Ergothioneine in diseases affecting millions of people world-wide.
